BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 26367261)

  • 1. [11C]MADAM Used as a Model for Understanding the Radiometabolism of Diphenyl Sulfide Radioligands for Positron Emission Tomography (PET).
    Gourand F; Amini N; Jia Z; Stone-Elander S; Guilloteau D; Barré L; Halldin C
    PLoS One; 2015; 10(9):e0137160. PubMed ID: 26367261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A radiometabolite study of the serotonin transporter PET radioligand [(11)C]MADAM.
    Gourand F; Emond P; Bergström JP; Takano A; Gulyás B; Guilloteau D; Barré L; Halldin C
    Nucl Med Biol; 2014 Jul; 41(6):501-6. PubMed ID: 24857865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of N,N-dimethyl-2-(2-amino-4-methylphenyl thio)benzylamine as a ligand of the serotonin transporter with high affinity and selectivity.
    Chalon S; Tarkiainen J; Garreau L; Hall H; Emond P; Vercouillie J; Farde L; Dasse P; Varnas K; Besnard JC; Halldin C; Guilloteau D
    J Pharmacol Exp Ther; 2003 Jan; 304(1):81-7. PubMed ID: 12490578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of PET radiometabolites by cytochrome P450, UHPLC/Q-ToF-MS and fast radio-LC: applied to the PET radioligands [11C]flumazenil, [18F]FE-PE2I, and [11C]PBR28.
    Amini N; Nakao R; Schou M; Halldin C
    Anal Bioanal Chem; 2013 Feb; 405(4):1303-10. PubMed ID: 23180082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [(11)C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PET.
    Halldin C; Lundberg J; Sóvágó J; Gulyás B; Guilloteau D; Vercouillie J; Emond P; Chalon S; Tarkiainen J; Hiltunen J; Farde L
    Synapse; 2005 Dec; 58(3):173-83. PubMed ID: 16138320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of 11C-MADAM binding to the serotonin transporter in the human brain.
    Lundberg J; Odano I; Olsson H; Halldin C; Farde L
    J Nucl Med; 2005 Sep; 46(9):1505-15. PubMed ID: 16157534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.
    Huang Y; Bae SA; Zhu Z; Guo N; Roth BL; Laruelle M
    J Med Chem; 2005 Apr; 48(7):2559-70. PubMed ID: 15801845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difficulties in dopamine transporter radioligand PET analysis: the example of LBT-999 using [18F] and [11C] labelling: part II: Metabolism studies.
    Peyronneau MA; Saba W; Dollé F; Goutal S; Coulon C; Bottlaender M; Valette H
    Nucl Med Biol; 2012 Apr; 39(3):347-59. PubMed ID: 22154687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docking study, synthesis, and in vitro evaluation of fluoro-MADAM derivatives as SERT ligands for PET imaging.
    Mavel S; Vercouillie J; Garreau L; Raguza T; Ravna AW; Chalon S; Guilloteau D; Emond P
    Bioorg Med Chem; 2008 Oct; 16(19):9050-5. PubMed ID: 18793858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proof of mechanism study of a novel serotonin transporter blocker, DA-8031, using [11C]DASB positron emission tomography and in vivo microdialysis.
    Park HS; Jung IS; Lim NH; Sung JH; Lee S; Moon BS; Lee BC; Kang KK; Kim SE
    Urology; 2014 Jul; 84(1):245.e1-7. PubMed ID: 24824409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human dosimetry of carbon-11 labeled N-butan-2-yl-1-(2-chlorophenyl)-N-methylisoquinoline-3-carboxamide extrapolated from whole-body distribution kinetics and radiometabolism in rats.
    Luoto P; Laitinen I; Suilamo S; Någren K; Roivainen A
    Mol Imaging Biol; 2010 Aug; 12(4):435-42. PubMed ID: 19941083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of serotonin transporter availability with [11C]MADAM--a comparison between the ECAT HRRT and HR systems.
    Schain M; Tóth M; Cselényi Z; Stenkrona P; Halldin C; Farde L; Varrone A
    Neuroimage; 2012 Mar; 60(1):800-7. PubMed ID: 22227138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in vivo evaluation of halogenated N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)benzylamine derivatives as PET serotonin transporter ligands.
    Jarkas N; Voll RJ; Williams L; Votaw JR; Owens M; Goodman MM
    J Med Chem; 2008 Jan; 51(2):271-81. PubMed ID: 18085744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin transporter in attention-deficit hyperactivity disorder--preliminary results from a positron emission tomography study.
    Karlsson L; Tuominen L; Huotarinen A; Leppämäki S; Sihvola E; Helin S; Sipilä M; Tani P; Hirvonen J; Hietala J; Karlsson H
    Psychiatry Res; 2013 May; 212(2):164-5. PubMed ID: 23566552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of serotonin transporter binding with PET and [11C]MADAM: a test-retest reproducibility study.
    Lundberg J; Halldin C; Farde L
    Synapse; 2006 Sep; 60(3):256-63. PubMed ID: 16752362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of [11C]DASB for measuring endogenous serotonin with PET: binding studies.
    Lundquist P; Wilking H; Höglund AU; Sandell J; Bergström M; Hartvig P; Långström B
    Nucl Med Biol; 2005 Feb; 32(2):129-36. PubMed ID: 15721758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.
    Plisson C; McConathy J; Martarello L; Malveaux EJ; Camp VM; Williams L; Votaw JR; Goodman MM
    J Med Chem; 2004 Feb; 47(5):1122-35. PubMed ID: 14971892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rat imaging and in vivo stability studies using [11C]-dimethyl-diphenyl ammonium, a candidate agent for PET-myocardial perfusion imaging.
    Jacobson O; Abourbeh G; Tsvirkun D; Mishani E
    Nucl Med Biol; 2013 Nov; 40(8):967-73. PubMed ID: 23999238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simplified radiometabolite analysis procedure for PET radioligands using a solid phase extraction with micellar medium.
    Nakao R; Halldin C
    Nucl Med Biol; 2013 Jul; 40(5):658-63. PubMed ID: 23602762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tyrosine kinase inhibitor PD153035: implication of labeling position on radiometabolites formed in vitro.
    Samén E; Thorell JO; Fredriksson A; Stone-Elander S
    Nucl Med Biol; 2006 Nov; 33(8):1005-11. PubMed ID: 17127174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.